Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE‐ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study

BACKGROUND: Guidelines recommend P2Y(12) inhibitor therapy for 1 year after myocardial infarction (MI), yet little guidance is provided on antiplatelet management for patients with recurrent ischemic events during that year. We describe changes in P2Y(12) inhibitor type among patients with recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanaroff, Alexander C., Kaltenbach, Lisa A., Peterson, Eric D., Akhter, Mohammed W., Effron, Mark B., Henry, Timothy D., Wang, Tracy Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850204/
https://www.ncbi.nlm.nih.gov/pubmed/29437596
http://dx.doi.org/10.1161/JAHA.117.007982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850204/
https://www.ncbi.nlm.nih.gov/pubmed/29437596
http://dx.doi.org/10.1161/JAHA.117.007982

Ejemplares similares